| à Brassard, Lothar (Chemagen 201102 CEO) |
Chief Executive Officer (CEO) |
PerkinElmer (Group) |
Germany |
| Aabo, Gitte (Leo Pharma 201511 CEO) |
Chief Executive Officer (CEO) |
Leo Pharma (Group) |
Denmark |
| Aamund, Asger (Bavarian Nordic 200804 Chairman) |
n. a. |
Bavarian Nordic (Group) |
Denmark |
| Aarts, Kees (Protix 202202 CEO + Founder) |
Chief Executive Officer (CEO) |
Protix B.V. |
Netherlands |
| Aasen, Ove T. (DiaMan AS 201804 CEO) |
Chief Executive Officer (CEO) |
DiaMan AS |
Norway |
| Aastrup, Teodor (Attana 200502) |
n. a. |
Attana (Group) |
Sweden |
| Aastveit, Are (Norwegian University for Biosciences and the Environment 200601) |
n. a. |
Norwegian University of Life Sciences (UMB) |
Norway |
| Abad-Molina, Maria (AgroSavfe 201402– Head of Product + Business Development before CropDesign) |
Business Development Manager / Strategy Manager |
Biotalys (Group) |
Belgium |
| Abastado, Jean-Pierre (Servier 201507 Director Oncology Innovation Therapeutic Pole) |
Research & Development Manager |
Servier (Group) |
France |
| Abate, Emmanuel (Danaher 202210 President Genomic Medicine at Cytiva) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United Kingdom (GB) |
| Abbey, Jeffrey (Jeff) (ImmunOs Therapeutics 202109– COO before Independent Consultant + Novadip Biosciences + Argos Tx) |
Chief Operating Officer (COO) |
ImmunOs Therapeutics AG |
Switzerland |
| Abbott, Mark (Peak Proteins 202204 CEO) |
Chief Executive Officer (CEO) |
Sygnature Discovery (Group) |
United Kingdom (GB) |
| Abbott, Rachel (Pan Cancer T 202305– CEO joined as CSO 1/23 before Enara Bio + Adaptimmune) |
Chief Executive Officer (CEO) |
Pan Cancer T B.V. |
Netherlands |
| Abbott, Raymond (Albany Ventures) |
n. a. |
Albany Ventures (Group) |
United Kingdom (GB) |
| Abdellaoui, Hautman (RED Horticulture 202311 CFO) |
Chief Financial Officer (CFO) |
RED Horticulture (Rouge Engineered Designs) (Group) |
France |
| Abdulkin, Pavel (Microcaps 202103 Sales + Business Development) |
Sales Manager / Marketing Manager |
Microcaps AG |
Switzerland |
| Abdullah, Hesham (GSK 202310 SVP Global Head Oncology RnD) |
Research & Development Manager |
GSK (Group) |
United Kingdom (GB) |
| Abecassis, William (BlackRock 202103 Head of Innovation Capital) |
Investment Manager |
BlackRock (Group) |
United States (USA) |
| Abend, Sven (Lonza 201903– COO of Lonza Specialty Ingredients segment) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Aberg, Louise (McDermott Will & Emery 201701 Associate in Life Sciences Group in Paris) |
Attorney / Lawyer |
McDermott Will & Emery (MWE) (Group) |
France |
| Aberman, Zami (Pluristem 201404 CEO) |
Chief Executive Officer (CEO) |
Pluristem (Group) |
Israel |
| Abery, Julian (BioCity (GB) 201909– Director Business Development North America at BioAscent Discovery) |
Business Development Manager / Strategy Manager |
Pioneer Group, The (WAPG) (Group) |
United Kingdom (GB) |
| Abi-Saab, Walid (Galapagos 201809 CMO) |
Chief Medical Officer (CMO) |
Galapagos (Group) |
Belgium |
| Abken, Hinrich (Univ Cologne 201507 Prof at CMMC) |
Professor |
University of Cologne (Universität zu Köln) |
Germany |
| Abou-Jamra, Hoda (Boston BioCapital FZ LLC + TVM Capital MENA 201002 Co-Founder) |
Company Founder |
TVM (Group) |
United Arab Emirates (UAE) |
| Abraham, Eytan (Lonza 201710 RnD Associate Director) |
n. a. |
Lonza (Group) |
Switzerland |
| Abraham, Robert (Pfizer 201412 SVP + CSO at Onology Research Unit) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pfizer (Group) |
United States (USA) |
| Abrams, Judith R. (Editas Medicine 201910– CMO before EMD Serono RnD Institute + CorMedix + Celgene + Novo Nordisk) |
Chief Medical Officer (CMO) |
Editas Medicine Inc. (Nasdaq: EDIT) |
United States (USA) |
| Abribat, Thierry (Alizé Pharma 2007– President + Founder) |
Chief Executive Officer (CEO) |
Alizé Pharma (Group) |
France |
| Absalonsen, Karin (Hannibal Innovation 202310) |
n. a. |
Hannibal Innovation ApS |
Denmark |
| Abshagen, Ulrich (Heidelberg Innovation 200503) |
n. a. |
Heidelberg Innovation (Group) |
Germany |
| Abu-Rabie, Paul (GSK 201010 Principal Scientist Bioanalytical Science & Development GSK R&D UK) |
Researcher (industry) |
GSK (Group) |
United Kingdom (GB) |
| Aburatani, Yoshihiro (RIKEN 201910 President of RIKEN Innovation Co Ltd) |
President/Director/Head Business Group/Unit/Division |
RIKEN Research Cluster for Innovation (JP) |
Japan |
| Acedo Becarés, Alberto (AC-Gen Reading Life 201503 Co-Founder + Technical Director) |
Chief Technology/Technical Officer (CTO) |
AC-Gen Reading Life S.L |
Spain (España) |
| Achard, Bruno (JEOL 201501 CEO of JEOL (Europe) SAS) |
Chief Executive Officer (CEO) |
JEOL (Group) |
France |
| Acharya, Anuradha (Ocimum Biosolutions 200408) |
n. a. |
Ficus Enterprises (Group) |
India |
| Achstetter, Tilmann (Hochschule Bremen 201303 Professor for Inudstrial Microbiology) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
| Ackerman, Yossi (former President + CEO of Elbit Systems) |
n. a. |
Elbit Systems Ltd. (TASE + Nasdaq: ESLT) |
|
| Ackermann, Bastian (Miltenyi Biotec 201807 Global Product Manager MACSQuant Tyto) |
Product Manager (personnel) |
Miltenyi Biotec (Group) |
Germany |
| Ackermann, Niels (BioXell 200704– CFO before Morgan Stanley London + CFO of two German biotech companies) |
Chief Financial Officer (CFO) |
Cosmo Pharmaceuticals (Group) |
Italy |
| Acosta, Colleen (Freya Biosciences 20231212 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Freya Biosciences ApS |
Denmark |
| Acton, Gary (Antisoma 200604– CMO) |
n. a. |
Sarossa Capital (Group) |
United Kingdom (GB) |
| Adair, Fiona (Haptogen 200507– before Biovation + CXR Biosciences) |
n. a. |
Pfizer (Group) |
United Kingdom (GB) |
| Adam, Maxine (United Kingdom (govt) 202310 Head of Business Growth at Innovate UK) |
Business Development Manager / Strategy Manager |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Adamis, Anthony P. (Jerini Ophthalmic 200703– CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
United States (USA) |
| Adamkiewicz, Maciej (Adamed 201108 CEO) |
Chief Executive Officer (CEO) |
Adamed (Group) |
Poland |
| Adams, Adrian (Auxilium 201112– CEO before Neurologix + Inspire Pharma + Sepracor + Kos + Novartis UK) |
Chief Executive Officer (CEO) |
Dainippon Sumitomo (Group) |
United States (USA) |
| Adams, Jan (Apollo Health Ventures 202109– Venture Partner before Merck KGaA + EMBL Ventures) |
Venture Partner |
Apollo Health Ventures (Group) |
Germany |
| Adams, Julian (Gamida Cell 201906 CEO) |
Chief Executive Officer (CEO) |
Gamida Cell Ltd. (Nasdaq: GMDA) |
Israel |
| Adams, Nicholas (Clavis Pharma 201107– CBO before Antisoma since 1999 BusDev Director + Manager + Ciba-Geiga + Eisai) |
Chief Business Officer (CBO) |
Aqualis ASA |
Norway |
| Adams, Thorsten (Sartorius 201705 Director of Product Management for Fermentation Technologies at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
| Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) |
Chief Financial Officer (CFO) |
ObsEva (Group) |
Switzerland |
| Adams, Tom (Pairwise 202308 CEO + Co-Founder before Monsanto 201708 VP Biotechnology) |
Chief Executive Officer (CEO) |
Pairwise (Group) |
United States (USA) |
| Adamski, J. (Helmholtz Zentrum München 200805 Head Gene Analysis Centre) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Ade, Michael (Strammer 201610 Partner + Top Management Consultant before Euromedica + Cellca + Ingenium) |
n. a. |
Strammer (Group) |
Germany |
| Adelhelm, Karin (Clondiag 200502) |
n. a. |
Abbott (Group) |
Germany |
| Adelman, Burt (Dyax 2012–2016 EVP + CMO before Eleven Biotherapeutics + Biogen) |
Board member, non-executive |
Takeda (Group) |
United States (USA) |
| Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial) |
Chief Executive Officer (CEO) |
Sebia (Group) |
France |
| Adermann, Knut (AMP Biosimilars AG 201504 COO) |
Chief Technology/Technical Officer (CTO) |
AMP Biosimilars AG |
Germany |
| Adermann, Knut (AMP-Therapeutics GmbH 201210 Managing Director) |
Managing Director |
Spexis (Group) |
Germany |
| Adewoye, Henry (Compugen 201803– CMO before Gilead Sciences + Amgen) |
Chief Medical Officer (CMO) |
Compugen (Group) |
Israel |
| Adiri, Yonatan (Healthy.io 201909 CEO + Founder) |
Chief Executive Officer (CEO) |
Healthy.io Ltd. |
Israel |
| Adkins, John (Sterilin 200806 CEO) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United Kingdom (GB) |
| Adlam, Leila (Inizio 202401 at Medistrava Consulting) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United Kingdom (GB) |
| Adler-Beutgen, Amalia (Fujifilm 200706 Product Manager Diagnostics) |
n. a. |
Fujifilm (Group) |
Germany |
| Adlersson, Lars (Medivir 200609 CEO + President) |
Chief Executive Officer (CEO) |
Medivir (Group) |
Sweden |
| Adlkofer, Kathrin (ai:do concepts GmbH 20111– Managing Director before Norgenta 2005–201202 Managing Director) |
Managing Director |
Cellbox Solutions (Group) |
Germany |
| Admon, Arie (Technion 201008 Prof Dept of Biology + Head Smoler Proteomics Center) |
Professor |
Technion – Israel Institute of Technology |
Israel |
| Adomakah, Nicholas (Novartis 202301 Sandoz Anti-infectives Global Medical Lead) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Adomat, Jens (Analytik Jena 1990–201312 Deputy Chairman of Executive Management Board + Co-founder LEFT 12/13) |
Board member, executive |
Endress+Hauser (Group) |
Germany |
| Adorján, Péter (Centogene 201502– Chief Business Development Officer before Epigenomics) |
Business Development Manager / Strategy Manager |
Centogene (Group) |
Germany |
| Adulamy, Maya (Valo Health 202012– Head of Strategic Partnerships based in Israel before at Maccabi) |
Business Development Manager / Strategy Manager |
Valo Health (Group) |
United States (USA) |
| Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Aebischer, Patrick (Ecole Polytechnique Fédérale 200808) |
n. a. |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
| af Winklerfelt, Michael (Oasmia 202008 CFO) |
Chief Financial Officer (CFO) |
Oasmia Pharmaceutical AB |
Sweden |
| Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) |
Chief Executive Officer (CEO) |
Flagship Pioneering |
United States (USA) |
| Affagard, Hervé (MaaT Pharma 201507 CEO) |
Chief Executive Officer (CEO) |
MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) |
France |
| Affara, Nabeel (Cambridge Univ Molecular Genetics Group 200211) |
n. a. |
University of Cambridge |
United Kingdom (GB) |
| Affentranger, Anton (Affentranger Associates 200803 CEO + Senior Partner + founder before Roche CFO) |
Chief Executive Officer (CEO) |
Affentranger Associates S.A. |
Switzerland |
| Afflerbach, Henning (Coral BioNet 201205 CBO at Scil Proteins) |
Chief Business Officer (CBO) |
UV-Cap (Vetter family office) (Group) |
Germany |
| Afonso, Carlos (Univ Rouen 201606) |
Laboratory Manager (industry) |
University of Rouen (Université de Rouen) |
France |
| Afshar, Ali (Cytera Cellworks 202011 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cytera CellWorks Ltd. |
United Kingdom (GB) |
| Afshar, Mohammad (Ariana Pharmaceuticals 2002– CEO + Founder) |
Chief Executive Officer (CEO) |
Ariana Pharmaceuticals (Group) |
France |
| Agamirzian, Igor (Russia (govt) 201203 CEO of RVC Russian Venture Capital) |
Chief Executive Officer (CEO) |
Russia (govt) |
Russian Federation |
| Agarwal, Shefali (Onxeo 202201 Board Chairwoman) |
Board member, non-executive |
Onxeo (Group) |
France |
| Agarwala, Sandip (Blue Owl Capital 202208 Managing Director at Owl Rock) |
Managing Director |
Blue Owl Capital (Group) |
United States (USA) |
| Aggarwal, Vijay (Aureon Laboratories 200410– before SKB + Quest Diagnostics) |
n. a. |
Aureon Laboratories Inc. |
United States (USA) |
| Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) |
Managing Partner (investment firm) |
Lundbeck (Group) |
Denmark |
| Agmoni, Eyal (Chartered Group 201910 Chairman) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Chartered Group |
|
| Agneter, Doris (Niederösterreich (govt) 200511 Managing Director of N.vest + Tecnet Equity) |
Managing Director |
Niederösterreich (govt region) |
Austria |
| Agon, Jean-Paul (L’Oréal 201812 CEO) |
Chief Executive Officer (CEO) |
L’Oréal (Group) |
France |
| Agostino-Etchetto, Florence (Lyonbiopole 201306– Managing Director joined 201209 before Hospices Civils de Lyon) |
Cluster Manager |
Lyonbiopôle |
France |
| Agrawal, Bhuwnesh (Sysmex 202004– Managing Director (CEO) of Sysmex Inostics GmbH before Eppendorf + Vela Dx + Roche) |
Managing Director |
Sysmex (Group) |
Germany |
| Agu, Chukwuma (ABS Biotechnologies GmbH 202401 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ABS Biotechnologies GmbH |
Austria |
| Aguiar, Michael (Theravance 200601 Senior VP + CFO) |
Chief Financial Officer (CFO) |
Innoviva (Group) |
United States (USA) |
| Aguiar, Sebastian (Samsara Therapeutics 201902 COO + Founder) |
Chief Operating Officer (COO) |
|
|
| Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) |
Chief Executive Officer (CEO) |
Calliditas Therapeutics (Group) |
Sweden |
| Aguilar, Carolina (Inbrain Therapeutics 202103 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Inbrain Neuroelectronics S.L. |
Spain (España) |
| Aguilar, Luc (L’Oréal 201402 Head of Biotechnologies Dept) |
President/Director/Head Business Group/Unit/Division |
L’Oréal (Group) |
France |
| Agus, David (Ellison Institute for Transformative Medicine 202205 Co-Founder) |
Company Founder |
Lawrence J. Ellison Institute for Transformative Medicine |
United States (USA) |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
